News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Katsuaki Maehara: New histopathologic indices to predict postoperative recurrence of lung cancer
Jul 28, 2024, 10:33

Katsuaki Maehara: New histopathologic indices to predict postoperative recurrence of lung cancer

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X about a recent paper by Yusuke Nagasaki et al. titled “Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer” published in JNCI.

Authors: Yusuke Nagasaki, Tetsuro Taki, Kotaro Nomura, Kenta Tane, Tomohiro Miyoshi, Joji Samejima, Keiju Aokage et al.

Katsuaki Maehara

“New histopathologic indices to predict postoperative recurrence of lung cancer.

Research paper finds that intratumor heterogeneity of PD-L1 is associated with postoperative relapse of lung cancer and death from cancer.”

Source: Katsuaki Maehara/X

cancer JNCI Joji Samejima Journal of the National Cancer Institute Katsuaki Maehara Keiju Aokage Kenta Tane Kotaro Nomura Lung cancer OncoDaily Oncology Research Tetsuro Taki Tomohiro Miyoshi Yusuke Nagasaki
Special Coverage
Insight
Aug 18, 2025, 18:55
NCODA Brings the BREAKWATER Trial into Practice
Blog Posts
Aug 18, 2025, 18:20
Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer
Voices
Aug 18, 2025, 17:43
Building a Healthier Future for Women Also Means Building a Healthier Future for the Next Generation - Elekta Foundation
Voices
Aug 18, 2025, 17:35
Mandar Muzumdar: The Evolution of Single-Cell 3D Genomes in KRAS-Driven Cancers
Blog Posts
Aug 18, 2025, 17:21
Douglas Flora: Create the Things You Wish Existed
Blog Posts
Aug 18, 2025, 17:13
Matt Yurgelun: Thrilled to Be Joining The Jimmy Fund Radio-Telethon
Voices
Aug 18, 2025, 17:04
Striking out Cancer for Patients Like Charlie - The Jimmy Fund
Insight
Aug 18, 2025, 16:52
Darren Haywood: Pleased to Receive COSA Endorsement of the MASCC COG-IMPACT Tool
Science
Aug 18, 2025, 16:48
Petros Grivas: Highlighting Intra-Patient Tumor Heterogeneity in Prostate Cancer Research
Science
Aug 18, 2025, 16:46
How Do We Select the Best 2L Therapy for Advanced EGFR‑Mutant NSCLC After Osimertinib? - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 16:37
Amanda Impellizzeri: What a Weekend at the Carolina Cancer Conference